Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Harrison

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Internal Medicine Journal|March 7, 2023
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma AustraliaShirlene Sim, Anna Kalff, Gina Tuch, et al.
Leukemia & Lymphoma|October 13, 2017
'Real-world' Australian experience of pomalidomide for relapsed and refractory myelomaAshleigh Scott, Nicholas Weber, Campbell Tiley, et al.
The Lancet. Haematology|July 1, 2022
[<sup>18</sup>F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trialAbby Douglas, Karin Thursky, Timothy Spelman, et al.
The Lancet. Infectious Diseases|July 25, 2018
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trialHolly Fisher, Yemi Oluboyede, Thomas Chadwick, et al.
Internal Medicine Journal|August 8, 2017
Bisphosphonate guidelines for treatment and prevention of myeloma bone diseaseOi Lin Lee, Noemi Horvath, Cindy Lee, et al.
Trials|June 5, 2016
Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): Study protocol for a randomised controlled trialCatherine Brennand, Alexander von Wilamowitz-Moellendorff, Sarah Dunn, et al.
Internal Medicine Journal|January 12, 2017
Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory GroupDipti Talaulikar, Constantine S Tam, Douglas Joshua, et al.
Health Technology Assessment (Winchester, England)|May 17, 2018
Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCTRobert Pickard, Thomas Chadwick, Yemi Oluboyede, et al.
Internal Medicine Journal|October 19, 2021
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma AustraliaKatherine Creeper, Bradley Augustson, Kieran Kusel, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Internal Medicine Journal|March 7, 2023
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma AustraliaShirlene Sim, Anna Kalff, Gina Tuch, et al.
Leukemia & Lymphoma|October 13, 2017
'Real-world' Australian experience of pomalidomide for relapsed and refractory myelomaAshleigh Scott, Nicholas Weber, Campbell Tiley, et al.
The Lancet. Haematology|July 1, 2022
[<sup>18</sup>F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trialAbby Douglas, Karin Thursky, Timothy Spelman, et al.
The Lancet. Infectious Diseases|July 25, 2018
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trialHolly Fisher, Yemi Oluboyede, Thomas Chadwick, et al.
Internal Medicine Journal|August 8, 2017
Bisphosphonate guidelines for treatment and prevention of myeloma bone diseaseOi Lin Lee, Noemi Horvath, Cindy Lee, et al.
Trials|June 5, 2016
Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): Study protocol for a randomised controlled trialCatherine Brennand, Alexander von Wilamowitz-Moellendorff, Sarah Dunn, et al.
Internal Medicine Journal|January 12, 2017
Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory GroupDipti Talaulikar, Constantine S Tam, Douglas Joshua, et al.
Health Technology Assessment (Winchester, England)|May 17, 2018
Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCTRobert Pickard, Thomas Chadwick, Yemi Oluboyede, et al.
Internal Medicine Journal|October 19, 2021
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma AustraliaKatherine Creeper, Bradley Augustson, Kieran Kusel, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Pageof 10